China Widens Drugmaker Probe

China Widens Drugmaker Probe Play

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. John Dawson reports on Bloomberg Television's "First Up." (Source: Bloomberg)

blog comments powered by Disqus